| Literature DB >> 31099319 |
Gloria Roberti1, Lucia Tanga1, Gianluca Manni1,2, Ivano Riva1, Alice Chandra Verticchio1, Francesca Berardo1, Carmela Carnevale1, Francesco Oddone1.
Abstract
Ocular surface disease is characterized by tear film instability and histopathologic and clinical changes of the ocular surface. Glaucoma patients often suffer from ocular surface disease caused by the chronic use of preserved medical treatment to reduce intraocular pressure. Benzalkonium chloride is the preservative most frequently used in glaucoma medications. Its effect on tear film, conjunctiva and cornea and the consequences in glaucoma management are discussed in this mini-review. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Glaucoma; benzalkonium chloride; corneal modification; ocular surface disease; preservative; tear film.
Mesh:
Substances:
Year: 2019 PMID: 31099319 DOI: 10.2174/0929867326666190517111823
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530